Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy?
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 344 (8928) , 979-982
- https://doi.org/10.1016/s0140-6736(94)91640-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving EstrogensNew England Journal of Medicine, 1986
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985
- EFFECT OF LONG‐TERM THERAPY WITH ESTROGEN AND PROGESTERONE ON THE ENDOMETRIUM OF POST‐MENOPASUAL WOMENActa Obstetricia et Gynecologica Scandinavica, 1985
- Endometrial hyperplasia in women on cyclic or continuous estrogen regimensFertility and Sterility, 1982
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Endometrial disease after treatment with oestrogens and progestogens in the climacteric.BMJ, 1980
- The effects of oestrogens and progestogens on the postmenopausal endometriumMaturitas, 1978
- Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal womenBMJ, 1978
- Estrogen Therapy for Postmenopausal FemalesNew England Journal of Medicine, 1965
- The Roles of Estrogen and Progesterone in Breast and Genital CancerPublished by American Medical Association (AMA) ,1962